$34.7 Million is the total value of Northpond Ventures, LLC's 3 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VIGIL NEUROSCIENCE INC | $22,716,144 | -42.7% | 4,214,498 | 0.0% | 65.40% | -0.5% | ||
| DNAY | TELESIS BIO INC | $10,237,895 | -34.2% | 9,844,130 | 0.0% | 29.48% | +14.2% | |
| CANDEL THERAPEUTICS INC | $1,780,398 | -27.0% | 1,935,215 | 0.0% | 5.13% | +26.7% | ||
| BLI | Exit | PHENOMEX INC | $0 | – | -5,390,820 | -100.0% | -4.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TELESIS BIO INC | 8 | Q3 2023 | 37.2% |
| CANDEL THERAPEUTICS INC | 8 | Q3 2023 | 6.0% |
| VIGIL NEUROSCIENCE INC | 7 | Q3 2023 | 65.8% |
| DICE THERAPEUTICS INC | 6 | Q1 2023 | 55.7% |
| ISOPLEXIS CORP | 5 | Q4 2022 | 28.3% |
| PHENOMEX INC | 2 | Q2 2023 | 4.4% |
View Northpond Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-06-02 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
View Northpond Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.